This 2022-23 flu season in the Northern Hemisphere arrived earlier than expected and we are also seeing a concerning increase in the number of respiratory syncytial virus (RSV) cases.

Governments and the global community must urgently tackle difficult questions about why, how, where, and when diagnostics, treatments, and vaccines are produced, and about who is in control of their availability and distribution.

The first step in SARS-CoV-2 genomic surveillance is testing to identify people who are infected. However, global testing rates are falling as we emerge from the acute health emergency and remain low in many low- and middle-income countries.

It summarises key information, practice guidelines and additional resources in a very practical manner. The Influenza Diabetes Community (IDC) has contributed to the chapter on people living with diabetes.

On 4 January, the Member States of the EU, in the presence of the Schengen Associated Countries, met in the framework of the Integrated Political Crisis Response (IPCR) to discuss the epidemiological situation in the EU/EEA and developments in China.

ECDC, together with the EU/EEA Member States and the European Commission has increased its monitoring activities and will revise risk assessments and adjust actions if needed.

Immunity from monovalent COVID-19 mRNA vaccination wanes over time. A bivalent COVID-19 mRNA booster dose is recommended for all eligible persons; however, little is known about its effectiveness against COVID-19 hospitalization.

The information on the coronavirus outbreak is continually evolving. The content within this activity serves as a historical reference to the information that was available at the time of this publication.

2022 has been a big year for diabetes research, filled with historic moments and world-firsts. Here we take a look back at some of the incredible progress Diabetes UK-funded scientists and diabetes researchers across the globe have been behind this year. 

Living with diabetes can be hard. The Influenza Hub seeks to educate and raise awareness about influenza and the best way to prevent getting infected by the flu virus.

It has been hypothesized that SARS-CoV-2 infection in children can increase risk of developing type 1 diabetes.

RSV infection in children is the most common viral respiratory infection and can cause severe lung damage or death. There is no licensed vaccine for preventing RSV infection.